Person

Samuel N. Hazen

CEO · Director, HCA Healthcare

Current S&P 500 boards
1
Current roles
1
Open-market buys
$0
Open-market sales
$56.2M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Feb 3, 2026HCASale14,716$502.95$7.4M
Feb 3, 2026HCASale5,002$502.15$2.5M
Feb 3, 2026HCASale7,395$500.69$3.7M
Feb 3, 2026HCASale6,189$500.02$3.1M
Feb 3, 2026HCASale5,162$498.80$2.6M
Feb 3, 2026HCASale4,293$498.12$2.1M
Feb 3, 2026HCASale120$497.18$60K
Nov 2, 2021HCASale3,159$252.44$797K
Nov 2, 2021HCASale38,260$251.84$9.6M
Nov 2, 2021HCASale8,581$250.96$2.2M
Nov 3, 2020HCASale5,000$136.63$683K
Nov 3, 2020HCASale44,099$135.02$6.0M
Nov 3, 2020HCASale72,776$135.90$9.9M
Jan 31, 2018HCASale56,000$100.47$5.6M

SEC reporting-owner ID (CIK) 1216838 · all filings on EDGAR

Samuel N. Hazen (HCA) | USBoard